First Time Loading...

Collegium Pharmaceutical Inc
NASDAQ:COLL

Watchlist Manager
Collegium Pharmaceutical Inc Logo
Collegium Pharmaceutical Inc
NASDAQ:COLL
Watchlist
Price: 37.51 USD Market Closed
Updated: May 5, 2024

Collegium Pharmaceutical Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Collegium Pharmaceutical Inc
Cash from Operating Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Collegium Pharmaceutical Inc
NASDAQ:COLL
Cash from Operating Activities
$274.7m
CAGR 3-Years
43%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash from Operating Activities
$23.2B
CAGR 3-Years
-1%
CAGR 5-Years
1%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Operating Activities
$13.7B
CAGR 3-Years
-1%
CAGR 5-Years
17%
CAGR 10-Years
12%
Pfizer Inc
NYSE:PFE
Cash from Operating Activities
$8.7B
CAGR 3-Years
-18%
CAGR 5-Years
-11%
CAGR 10-Years
-7%
Merck & Co Inc
NYSE:MRK
Cash from Operating Activities
$13B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
1%
Eli Lilly and Co
NYSE:LLY
Cash from Operating Activities
$3.7B
CAGR 3-Years
-22%
CAGR 5-Years
-7%
CAGR 10-Years
-4%

See Also

What is Collegium Pharmaceutical Inc's Cash from Operating Activities?
Cash from Operating Activities
274.7m USD

Based on the financial report for Dec 31, 2023, Collegium Pharmaceutical Inc's Cash from Operating Activities amounts to 274.7m USD.

What is Collegium Pharmaceutical Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
10%

Over the last year, the Cash from Operating Activities growth was 121%. The average annual Cash from Operating Activities growth rates for Collegium Pharmaceutical Inc have been 43% over the past three years , 10% over the past five years .